Cargando…
Degradation strategy of cyclin D1 in cancer cells and the potential clinical application
Cyclin D1 has been reported to be upregulated in several solid and hematologic tumors, promoting cancer progression. Thus, decreasing cyclin D1 by degradation could be a promising target strategy for cancer therapy. This mini review summarizes the roles of cyclin D1 in tumorigenesis and progression...
Autores principales: | Chen, Shuyi, Li, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434365/ https://www.ncbi.nlm.nih.gov/pubmed/36059670 http://dx.doi.org/10.3389/fonc.2022.949688 |
Ejemplares similares
-
The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis
por: Aldaalis, Arwa, et al.
Publicado: (2022) -
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
por: Alao, John P
Publicado: (2007) -
Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Hao, Junmei, et al.
Publicado: (2021) -
Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma
por: Cai, Wei, et al.
Publicado: (2023) -
Myeloid Differentiation Primary Response 88–Cyclin D1 Signaling in Breast Cancer Cells Regulates Toll-Like Receptor 3-Mediated Cell Proliferation
por: Singh, Aradhana, et al.
Publicado: (2020)